Quantum Biopharma Ltd. Files May 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 19, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their May 6-K, sticking with the 20-F annual report format.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 19, 2025, reporting for the month of May 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's regulatory reporting status, confirming their adherence to SEC requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine filing confirming reporting status and does not contain new financial or operational information.
Key Numbers
- 001-39152 — Commission File Number (Identifies the company's SEC filings)
- 2834 — SIC Code (Industry classification for Pharmaceutical Preparations)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- May 19, 2025 (date) — Filing date of the 6-K
- 20250519 (date) — Conformed period of report
- 001-39152 (dollar_amount) — Commission File Number
- 2834 (dollar_amount) — Standard Industrial Classification for Pharmaceutical Preparations
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.
What was Quantum Biopharma Ltd. previously known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The SIC code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding Quantum Biopharma Ltd. (QNTM).